Gematologiya i Transfuziologiya

Papers
(The TQCC of Gematologiya i Transfuziologiya is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Supplement intravenous iron therapy in cardiac surgery8
Blood groups and acute respiratory viral infection COVID-198
Physiological and pathological role of factor XII4
The effect of phototherapy on the dynamics of cytokine mRNA expression in the affected skin of patients with mycosis fungoides4
MEK-kinase Inhibitor as a treatment option for hairy cell leukemia4
Role of the intensive care in allogeneic hematopoietic stem cell transplantation4
Using a thrombodynamics test for diagnostics of hypercoagulation and prediction of thromboembolic complications in patients with malignant tumors4
The frequency of detection of anti-HBc in blood donors from four regions of Russia3
Methodological aspects of the detection of minimal residual disease in patients with acute leukemia3
Contribution of social and demographic parameters to the long-term survival prognosis of chronic myeloid leukemia patients3
Thrombotic thrombocytopenic purpura in pregnancy. Giving birth or not giving birth, that is the question3
The characterization and frequency of diagnosis of EBV-positive variants with a lymphoid predominance in the structure of Hodgkin lymphoma3
Early and late relapses of multiple myeloma after autologous haematopoietic stem cell transplantation3
Impact of natural killer cell’s functional reconstruction on the results of allogeneic hematopoietic stem cell transplantation2
Incidence and mortality rates of tumors of the hematopoietic and lymphoid tissues in a cohort of workers chronically exposed to ionizing radiation2
Evaluation of the relative allelic load of mutations of resistance to ibrutinib in the <i>BTK</i> gene by allele-specific PCR in patients with progression of CLL2
Mechanisms of action of immunomodulatory drugs — from teratogenicity to treatment of multiple myeloma2
Myeloidderived peripheral blood suppressor cells at haematopoietic stem cell mobilisation in multiple myeloma patients2
The use of a growth factor inhibitor in the treatment of recurrent bleeding in von Willebrand disease2
Thromboelastometry for predicting hemostasis disorders after cardiopulmonary bypass during cardiac surgery2
Acute lymphoblastic leukemias in twins2
Platelet Delta granules storage pool deficiency in female patient with severe hemorrhagic syndrome2
Comparison of morbidity and results of chronic myeloid leukemia treatment in Novosibirsk and the Novosibirsk region2
Safety of plasma-derived blood products transfusions harvested from anti-SARS-CoV-2 positive and negative donors1
Vaccination against COVID-19 for hematologic patients: A review of clinical guidelines1
Structure and prognostic signifi cance of 13q14 deletion in chronic lymphocytic leukemia1
Biopsy-free diagnosis of primary diffuse large B-cell lymphoma of the central nervous system1
Expression of PD-1 and TIM-3 inhibitory checkpoint molecules by T-lymphocytes in early post-transplant period in multiple myeloma patients1
Indicators of iron metabolism in regular donors of blood platelets and plasma1
Management of patients with hemophilia A on emicizumab prophylactic treatment: Recommendation from Russian Experts1
Long-term results of therapy for chronic myeloid leukemia: a 20-year analysis of the use of tyrosine kinase inhibitors in Russia1
Treatment results of children and adolescents with relapsed AML who were initially treated according to the AML-MM-2006 protocol1
Storage of pathogen-reduced platelets1
Interim results of the PML-16, PML-19 protocols for primary mediastinal large B-cell lymphoma therapy1
Comparison of quantitative and qualitative characteristics of the system “P-selectin — platelets — von Willebrand factor — metalloprotease ADAMTS13” in patients with sepsis, idiopathic thrombocytopeni1
How I treat peripheral T-cell lymphomas1
Successful treatment of relapses of primary mediastinal large B-cell lymphoma with central nervous system involvement1
Thrombosis in patients with hereditary fibrinogen deficiency1
Formation of collective immunity against a new coronavirus infection COVID-19 in blood donors1
Prevention of ischemic stroke in patients with myeloproliferative neoplasms1
Hereditary combined deficiency of factors V and VIII: observations in the Russian population1
Qualitative platelet alterations in May — Hegglin anomaly1
The incidence of Ph-negative chronic myeloproliferative neoplasms in Belarus1
The Role of epigenetic modifications of DNA and histones in the treatment of oncohematological diseases1
Guidelines for the diagnosis and management of idiopathic thrombocytopenic purpura1
Comparison of the effectiveness of supportive chemotherapy for patients with acute myeloid leukemia1
Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute leukemia1
Surgical treatment of hemophilic arthropathy of subtalar joint in a patient with severe hemophilia B1
Acute tumor lysis syndrome — an urgent multidisciplinary problem in pediatric hematology1
Study of the Janus kinase 2 (JAK2) gene haplotype 46/1 association with driver mutations of chronic Ph-negative myeloproliferative neoplasms1
Blood groups and oncological diseases1
Characteristics and trends in the work of the Blood Service of the Russian Federation in 2016–20201
Efficacy of anti-CD19 CAR-T therapy after bispecific monoclonal antibody (CD19/CD3) therapy in a patient with relapsed Ph-positive acute lymphoblastic leukemia with a massive extramedullary component1
Molecular and genetic verification of von Willebrand disease type 2N1
Immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura — diagnostic difficulties and errors1
First modern Russian plasma-derived coagulation factor VIII concentrate (Eytoplasm): Results of clinical study of pharmacokinetics, efficacy and safety1
Haemovigilance in the United Kingdom1
Analysis of microsatellite instability in primary mediastinal large B-cell lymphoma: Focus on PD-L1/PD-L2 and CIITA1
COVID-19 infection in patients undergoing allogeneic hematopoietic stem cell transplantation1
0.085755109786987